- Home
- GOAI vs BSEM Comparison
GOAI vs BSEM Comparison
Compare GOAI & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOAI | BSEM |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 76.9M |
| IPO Year | 2023 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GOAI | BSEM |
|---|---|---|
| Price | $1.79 | $3.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 181.6K | 144.6K |
| Earning Date | 04-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,037,328.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 82.59 | N/A |
| 52 Week Low | $1.42 | $2.25 |
| 52 Week High | $6.67 | $5.44 |
Technical Indicators
Market Signals| Indicator | GOAI | BSEM |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 49.99 |
| Support Level | $1.62 | $3.69 |
| Resistance Level | $2.66 | $4.65 |
| Average True Range (ATR) | 0.32 | 0.46 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 3.77 | 17.56 |
Price Performance
Historical ComparisonAbout GOAI Eva Live Inc. Common Stock
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.
About BSEM BioStem Technologies Inc. Common Stock
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.